TABLE 3.
Complete | Partial | Progressive | Stable | |
---|---|---|---|---|
response | response | disease | disease | |
Target lesion size | Disappearance of all lesions | 30% or more decrease in the sum longest diameter | 20% or more increase in the sum longest diameter; at least one lesion increased by 5 mm | 30% or more decrease from baseline but 20% in sum longest diameter from nadir |
New lesions | None | None | Yes | None |
Corticosteroid use | No use | Stable to decreased | N/A | Stable to decreased |
Neurological symptoms | Stable or improved | Stable or improved | Worse | Stable or improved |
Criteria to assess for intracranial response in brain metastases and with the use of immunotherapy. Reprinted from Lin et al61 with permission from Elsevier.